GIL BASHE ON MEDIKA LIFE

Science Has No Borders – And Neither Should Human Potential

Global Collaboration in health and science at HIMSS AI in Healthcare Forum offers a blueprint for a more connected, compassionate and innovative future.

Here at the HIMSS AI in Healthcare Forum, held in Brooklyn—long a gateway for immigration and innovation—the gathering has become more than just a platform to explore the intersection of “artificial intelligence” and human health. The gathering serves as a reminder of a deeper truth: science and human progress are fueled by global collaboration, and talent knows no borders. This welcoming approach is something that the Health Information Management System Services (HIMSS uniquely practices.

A Conversation Without Borders

Among the diverse voices at the Forum were three standout attendees—one from Ghana, another from Brazil, and still another from India—all deeply committed to advancing scientific discovery and digital transformation in health, all sitting at one table coincidentally. Their presence reinforced the idea that innovation emerges not from a single system or nation but from a mosaic of lived experiences, cultural insight, and shared human purpose.

At a time when geopolitical divisions grow and xenophobic rhetoric clouds practical need, this convening of minds from across continents stands as a counterpoint: progress in medicine and public health demands openness, not isolation.

Today, two out of five HIMSS members live outside the United States, representing the tremendous growth in its international reach.

Global Minds and Shared Missions

Consider the stories behind some of the most transformative scientific breakthroughs. Dr. Tu Youyou, who drew upon traditional Chinese medicine to isolate artemisinin, reshaped malaria treatment and saved millions. Tu received the 2011 Lasker Award in clinical medicine and the 2015 Nobel Prize in Physiology or Medicine jointly with William C. Campbell and Satoshi Ōmura for her work.

Dr. Salvador Moncada, born in Honduras and later based in the UK, changed the future of cardiovascular medicine through his work on nitric oxide. And Dr. Pardis Sabeti, born in Iran and raised in the United States, played a critical role in genomic tracking during the West African Ebola outbreak. These are not anomalies—they are the natural result of cross-border learning and purpose-driven science. In recognition of his tapping into the power of collaboration to accelerate biomedical discoveries, Dr. Salvador was nominated by the President of Honduras to serve as the country’s first Ambassador to China. 

Such examples underscore a larger point: global health challenges—from infectious disease to chronic illness—cannot be solved in silos. They require knowledge sharing, inclusive research, and the integration of clinical science, population health data, and epidemiological insights gathered across geographies. HIMSS is paving the way for people and countries to come together.

Today, health information flows freely across continents. Clinical trials are increasingly multinational. Genomic datasets used to train AI models include samples from diverse populations. Epidemiological patterns—from outbreaks to noncommunicable disease trends—are informed by data from regions that span income levels and infrastructure capacity. This global interconnectedness of knowledge is not only valuable—it is vital.

Health innovation now depends as much on access to ideas and information as on access to raw data or funding. Each individual—whether a clinician, data scientist, policymaker, patient or communicator—contributes to this ecosystem through their choices within their workplace, organization, advocacy group and community. These local actions ripple outward to impact global outcomes.

When people are empowered to think boldly and act collaboratively—regardless of where they are from—their influence transcends borders. This is especially true in a world where diseases migrate, health inequities persist, and environmental factors increasingly shape population health. No one country has a monopoly on the future of medicine, and no one person is immune to illness.

Science and Technology as a Bridge

Science is not merely technical; it is relational. It is built on trust, transparency, and the willingness to share. When data is exchanged openly—on disease trends, therapeutic outcomes, or environmental health risks—it becomes a force for public good. When it is withheld or politicized, it delays solutions and costs lives.

As HIMSS convened global thinkers in a borough symbolic of reinvention, the message was clear: advancing AI in health is not just about algorithms—it’s about equity, empathy, and inclusion. Those values begin not with policy mandates but with people. Beneath sessions on technology and policies, the conversation continually returned to the reality—it’s about people working collaboratively.

Every organization has the power to foster a culture where global voices are welcomed, collaboration is incentivized, and ideas are judged not by origin but by merit. The future of health will be shaped by how willing we are to embrace human potential, wherever it begins, and work with people who can help advance human health wherever they call home.

Brooklyn as a Setting and Symbol

Photo Credit: author – A packed room – even early in the morning – as attendees from around the United States and the world absorb the counsel of speakers and panelists share their wisdom with each other.

Brooklyn is a fitting backdrop for these conversations. A city defined by generations of immigrants—scientists, healers and visionaries—stands as a beacon for what is possible when people are welcomed, not walled off. HIMSS is hosting its APAC meeting July 16-18 in Malaysia.

The HIMSS AI in Healthcare Forum brought together technologists, clinicians, ethicists and entrepreneurs. But more than that, it reminds participants of something timeless: when diverse minds come together, knowledge is not only shared—it is elevated. When human potential is honored without prejudice, the possibilities for better health are limitless.

PATIENT ADVISORY

Medika Life has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by Medika Life

Gil Bashe, Medika Life Editor
Gil Bashe, Medika Life Editorhttps://gil-bashe.medium.com/
Health advocate connecting the dots to transform biopharma, digital health and healthcare innovation | Managing Partner, Chair Global Health FINN Partners | MM&M Top 50 Health Influencer | Top 10 Innovation Catalyst. Gil is Medika Life editor-in-chief and an author for the platform’s EcoHealth and Health Opinion and Policy sections. Gil also hosts the HealthcareNOW Radio show Healthunabashed, writes for Health Tech World, and is a member of the BeingWell team on Medium.

GIL BASHE

Editor in Chief, Medika Life

Meet the Medika Life editor-in-chief, working closely with founding editors Robert Turner and Jeff Livingston, MD.

Not your usual health-industry executive, Gil Bashe has had a unique career shaped by more than three decades in health policy, pharma, life science, digital health, eco-health, environmental innovation and venture capital and informed his determination to ‘give back.’

A champion for health innovation that sustains people’s lives and improves their care, Gil honed his perspectives on both battlefield and boardroom. He started in health as a combat medic in an elite military unit. He went on to serve as a clergyman tending to the ill; as a health products industry lobbyist in environmental affairs; as CEO of one of the world’s largest integrated health marketing companies; as a principal in a private equity-backed venture; as a Medika Life author and Health Tech World correspondent; and as Chair Global Health and Purpose at FINN Partners, a community of purpose dedicated to making a difference.

In the forefront of change, Gil is ranked as a Top 10 Digital Health Influencer; Medical Marketing & Media Top 10 Innovation Catalyst; Medika Life named him a “Top 50 Global Healthcare Influencer,” and PM360 presented him with its “Trailblazer Lifetime Achievement Award.” He is a board member for digital health companies and is an advisor to the CNS Summit, Galien Foundation, Let’s Win for Pancreatic Cancer, Marfan Foundation and other health-centered organizations.

CONNECT WITH GIL

ON TWITTER

ON LINKEDIN

ON MEDIUM

All articles, information and publications featured by the author on thees pages remain the property of the author. Creative Commons does not apply and should you wish to syndicate, copy or reproduce, in part or in full, any of the content from this author, please contact Medika directly.